6.ALPHA.,9-DIFLUORO-5',16.BETA.-DIHYDRO-11.BETA.,21-DIHYDROXYPREGNA-1,4-DIENO(17,16-C)PYRAZOLE-3,20-DIONE 21-VALERATE
UNII J47GZ893LE
Substance Identification & Data
This profile provides standardized clinical and technical data for 6.alpha.,9-difluoro-5',16.beta.-dihydro-11.beta.,21-dihydroxypregna-1,4-dieno(17,16-c)pyrazole-3,20-dione 21-valerate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) J47GZ893LE.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 94135-38-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C27H34F2N2O5 IVKTWEUOWAMBNB-MOWALVJDSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 6.alpha.,9-difluoro-5',16.beta.-dihydro-11.beta.,21-dihydroxypregna-1,4-dieno(17,16-c)pyrazole-3,20-dione 21-valerate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.